The demo went great. The physician loves it. And the deal still dies — because healthcare software is bought by a committee, and you only pitched one seat.
Anatolie Clevan · Founder, LeadsACE · Updated June 11, 2026Healthcare software isn't bought by the person who loves your demo. It's bought by a committee of 6–10 people, most of whom you'll never meet — and each one can kill the deal for a different reason:
| Role | What they fear | What convinces them |
|---|---|---|
| Clinical champion | Looking foolish for backing you | Peer proof — named clinics, named outcomes |
| Practice admin / ops | Workflow disruption, staff revolt | An implementation plan measured in days, not quarters |
| IT / security | Integration debt, a breach with their name on it | EMR integration specifics, SOC 2, a clean security packet |
| Compliance | HIPAA exposure | BAA ready to sign, data-flow diagram on request |
| CFO / owner | Paying for software that doesn't move a number | ROI math in their units: chairs filled, calls answered, hours saved |
The most expensive illusion in healthtech sales: the demo went great, the physician said "we need this," and the deal feels done. It isn't. Behind that one champion sit five silent vetoes — people who weren't in the demo, owe you nothing, and default to no:
A deal is won when every veto has been answered — before it's cast. Your champion can't do that alone; your job is to arm them.
Your champion will repeat your pitch to the committee badly — unless you hand them the exact artifacts each member needs:
HIPAA review, SOC 2 questionnaires, security audits, legal redlines — in healthcare these aren't exceptions, they're the path. A "closed" deal that hits procurement unprepared freezes for months. The fix is sequencing: have the packet ready before the first demo, answer the questionnaire before it's sent, and treat procurement as a stakeholder you're selling to — not an obstacle that appears at the end.
Soft benefits don't survive a budget meeting. Before the committee votes, the CFO needs one number: what does this return, in our units, by when? Build it conservatively — calls answered, no-shows recovered, staff hours saved, revenue per chair — and let them stress-test the assumptions. A defensible small number beats an impressive fragile one. This is the difference between a pilot that converts and a pilot that gets praised (we wrote a separate playbook on that).
This is the motion behind the numbers on our Dripify case — 160+ enterprise accounts and a 280-seat deal, all committee sales — and behind Voxira's 12 signed clinics before the product was even finished.
Praised pilots stall for structural reasons. Design one that's built to close.
The real cost math on your first sales hire — from someone who's been both.
What unanswered phones and slow follow-up actually cost a practice per year.
Typically 6–10 people: the clinical champion, the day-to-day user, IT and security, compliance (HIPAA/SOC 2), procurement, and the CFO or economic buyer. Each carries a different risk, and the deal stalls when even one silent veto goes unaddressed.
A champion can recommend but rarely sign. Deals close when every committee member gets an answer to their specific risk — a single unaddressed veto from security, procurement, or finance freezes a 'closed' deal for months.
Prepare for it before you're in it. Have security documentation, references, and the ROI case ready so a 'closed' deal doesn't hit procurement cold, and arm your champion with the exact materials each gatekeeper needs.
A credible ROI case they can defend — the cost of the problem today versus the price, in the CFO's own numbers. That math comes last and decides everything, which is why the pilot's real job is to produce the CFO's slide.